ter Meulen Jan Henrik 4
4 · IMMUNE DESIGN CORP. · Filed Nov 9, 2018
Insider Transaction Report
Form 4
ter Meulen Jan Henrik
Chief Scientific Officer
Transactions
- Award
Common Stock
[F1][F2]2018-11-07+23,362→ 62,396 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Immune Design Corp. common stock.
- [F2]Restricted stock units shall vest in a single installment on November 7, 2019, subject to the Reporting Person's continuous service through such date.
Signature
/s/ Stephen R. Brady, Attorney-In-Fact|2018-11-09